-
1
-
-
36048980049
-
Current immunotherapeutic strategies in lung cancer
-
Rüttinger, D., R. A. Hatz, K. W. Jauch, and B. A. Fox. 2007. Current immunotherapeutic strategies in lung cancer. Surg. Oncol. Clin. N. Am. 16: 901-918.
-
(2007)
Surg. Oncol. Clin. N. Am.
, vol.16
, pp. 901-918
-
-
Rüttinger, D.1
Hatz, R.A.2
Jauch, K.W.3
Fox, B.A.4
-
2
-
-
42649107514
-
New insights in drug development for the non-small cell lung cancer therapy
-
Gridelli, C., A. Rossi, P. Maione, C. Ferrara, F. Del Gaizo, C. Guerriero, D. Nicolella, G. Palazzolo, M. Falanga, and G. Colantuoni. 2008. New insights in drug development for the non-small cell lung cancer therapy. Front. Biosci. 13: 5108-5119.
-
(2008)
Front. Biosci.
, vol.13
, pp. 5108-5119
-
-
Gridelli, C.1
Rossi, A.2
Maione, P.3
Ferrara, C.4
Del Gaizo, F.5
Guerriero, C.6
Nicolella, D.7
Palazzolo, G.8
Falanga, M.9
Colantuoni, G.10
-
3
-
-
0345358584
-
The IL-12 family of heterodimeric cytokines: New players in the regulation of T cell responses
-
Trinchieri, G., S. Pflanz, and R. A. Kastelein. 2003. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19: 641-644.
-
(2003)
Immunity
, vol.19
, pp. 641-644
-
-
Trinchieri, G.1
Pflanz, S.2
Kastelein, R.A.3
-
4
-
-
21844444831
-
New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions
-
Hunter, C. A. 2005. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat. Rev. Immunol. 5: 521-531.
-
(2005)
Nat. Rev. Immunol.
, vol.5
, pp. 521-531
-
-
Hunter, C.A.1
-
5
-
-
3142709474
-
Understanding the pro- And anti-inflammatory properties of IL-27
-
Villarino, A. V., E. Huang, and C. A. Hunter. 2004. Understanding the pro- and anti-inflammatory properties of IL-27. J. Immunol. 173: 715-720.
-
(2004)
J. Immunol.
, vol.173
, pp. 715-720
-
-
Villarino, A.V.1
Huang, E.2
Hunter, C.A.3
-
6
-
-
0038326688
-
Cutting edge: Role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment
-
Takeda, A., S. Hamano, A. Yamanaka, T. Hanada, T. Ishibashi, T. W. Mak, A. Yoshimura, and H. Yoshida. 2003. Cutting edge: role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J. Immunol. 170: 4886-4890.
-
(2003)
J. Immunol.
, vol.170
, pp. 4886-4890
-
-
Takeda, A.1
Hamano, S.2
Yamanaka, A.3
Hanada, T.4
Ishibashi, T.5
Mak, T.W.6
Yoshimura, A.7
Yoshida, H.8
-
8
-
-
0842347431
-
Potent antitumor activity of interleukin-27
-
Hisada, M., S. Kamiya, K. Fujita, M. L. Belladonna, T. Aoki, Y. Koyanagi, J. Mizuguchi, and T. Yoshimoto. 2004. Potent antitumor activity of interleukin-27. Cancer Res. 64: 1152-1156.
-
(2004)
Cancer Res.
, vol.64
, pp. 1152-1156
-
-
Hisada, M.1
Kamiya, S.2
Fujita, K.3
Belladonna, M.L.4
Aoki, T.5
Koyanagi, Y.6
Mizuguchi, J.7
Yoshimoto, T.8
-
9
-
-
10344228778
-
+ T cells
-
+ T cells. J. Immunol. 173: 7170-7182.
-
(2004)
J. Immunol.
, vol.173
, pp. 7170-7182
-
-
Salcedo, R.1
Stauffer, J.K.2
Lincoln, E.3
Back, T.C.4
Hixon, J.A.5
Hahn, C.6
Shafer-Weaver, K.7
Malyguine, A.8
Kastelein, R.9
Wigginton, J.M.10
-
10
-
-
33744909098
-
Antiangiogenic and antitumor activities of IL-27
-
Shimizu, M., M. Shimamura, T. Owaki, M. Asakawa, K. Fujita, M. Kudo, Y. Iwakura, Y. Takeda, A. D. Luster, J. Mizuguchi, and T. Yoshimoto. 2006. Antiangiogenic and antitumor activities of IL-27. J. Immunol. 176: 7317-7324.
-
(2006)
J. Immunol.
, vol.176
, pp. 7317-7324
-
-
Shimizu, M.1
Shimamura, M.2
Owaki, T.3
Asakawa, M.4
Fujita, K.5
Kudo, M.6
Iwakura, Y.7
Takeda, Y.8
Luster, A.D.9
Mizuguchi, J.10
Yoshimoto, T.11
-
11
-
-
45549106117
-
Antiproliferative activity of IL-27 on melanoma
-
Yoshimoto, T., N. Morishima, I. Mizoguchi, M. Shimizu, H. Nagai, S. Oniki, M. Oka, C. Nishigori, and J. Mizuguchi. 2008. Antiproliferative activity of IL-27 on melanoma. J. Immunol. 180: 6527-6535.
-
(2008)
J. Immunol.
, vol.180
, pp. 6527-6535
-
-
Yoshimoto, T.1
Morishima, N.2
Mizoguchi, I.3
Shimizu, M.4
Nagai, H.5
Oniki, S.6
Oka, M.7
Nishigori, C.8
Mizuguchi, J.9
-
12
-
-
3042665905
-
Cyclooxygenase as a target in lung cancer
-
Brown, J. R., and R. N. DuBois. 2004. Cyclooxygenase as a target in lung cancer. Clin. Cancer Res. 10: 4266s-4269s.
-
(2004)
Clin. Cancer Res.
, vol.10
-
-
Brown, J.R.1
DuBois, R.N.2
-
13
-
-
0141562299
-
Lung cancer and cyclooxygenase-2
-
Castelao, J. E., R. D. Bart, III, C. A. DiPerna, E. M. Sievers, and R. M. Bremner. 2003. Lung cancer and cyclooxygenase-2. Ann. Thorac. Surg. 76: 1327-1335.
-
(2003)
Ann. Thorac. Surg.
, vol.76
, pp. 1327-1335
-
-
Castelao, J.E.1
Bart III, R.D.2
DiPerna, C.A.3
Sievers, E.M.4
Bremner, R.M.5
-
14
-
-
0032170955
-
Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas
-
Hida, T., Y. Yatabe, H. Achiwa, H. Muramatsu, K. Kozaki, S. Nakamura, M. Ogawa, T. Mitsudomi, T. Sugiura, and T. Takahashi. 1998. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res. 58: 3761-3764.
-
(1998)
Cancer Res.
, vol.58
, pp. 3761-3764
-
-
Hida, T.1
Yatabe, Y.2
Achiwa, H.3
Muramatsu, H.4
Kozaki, K.5
Nakamura, S.6
Ogawa, M.7
Mitsudomi, T.8
Sugiura, T.9
Takahashi, T.10
-
15
-
-
0032533858
-
Expression of cyclooxygenase-2 in human lung carcinoma
-
Wolff, H., K. Saukkonen, S. Anttila, A. Karjalainen, H. Vainio, and A. Ristimaki. 1998. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res. 58: 4997-5001. (Pubitemid 28521147)
-
(1998)
Cancer Research
, vol.58
, Issue.22
, pp. 4997-5001
-
-
Wolff, H.1
Saukkonen, K.2
Anttila, S.3
Karjalainen, A.4
Vainio, H.5
Ristimaki, A.6
-
16
-
-
12144291145
-
Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer
-
Põld, M., L. X. Zhu, S. Sharma, M. D. Burdick, Y. Lin, P. P. Lee, A. Põld, J. Luo, K. Krysan, M. Dohadwala, et al. 2004. Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer. Cancer Res. 64: 1853-1860.
-
(2004)
Cancer Res.
, vol.64
, pp. 1853-1860
-
-
Põld, M.1
Zhu, L.X.2
Sharma, S.3
Burdick, M.D.4
Lin, Y.5
Lee, P.P.6
Põld, A.7
Luo, J.8
Krysan, K.9
Dohadwala, M.10
-
17
-
-
0346736504
-
2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion
-
2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion. J. Biol. Chem. 277: 50828-50833.
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 50828-50833
-
-
Dohadwala, M.1
Batra, R.K.2
Luo, J.3
Lin, Y.4
Krysan, K.5
Pold, M.6
Sharma, S.7
Dubinett, S.M.8
-
18
-
-
0034026144
-
Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines
-
Hida, T., K. Kozaki, H. Muramatsu, A. Masuda, S. Shimizu, T. Mitsudomi, T. Sugiura, M. Ogawa, and T. Takahashi. 2000. Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. Clin. Cancer Res. 6: 2006-2011.
-
(2000)
Clin. Cancer Res.
, vol.6
, pp. 2006-2011
-
-
Hida, T.1
Kozaki, K.2
Muramatsu, H.3
Masuda, A.4
Shimizu, S.5
Mitsudomi, T.6
Sugiura, T.7
Ogawa, M.8
Takahashi, T.9
-
19
-
-
20444464066
-
+ T regulatory cell activities in lung cancer
-
+ T regulatory cell activities in lung cancer. Cancer Res. 65: 5211-5220.
-
(2005)
Cancer Res.
, vol.65
, pp. 5211-5220
-
-
Sharma, S.1
Yang, S.C.2
Zhu, L.3
Reckamp, K.4
Gardner, B.5
Baratelli, F.6
Huang, M.7
Batra, R.K.8
Dubinett, S.M.9
-
20
-
-
23244437041
-
Cyclooxygenase 2 inhibition promotes IFN-γ-dependent enhancement of antitumor responses
-
Sharma, S., L. Zhu, S. C. Yang, L. Zhang, J. Lin, S. Hillinger, B. Gardner, K. Reckamp, R. M. Strieter, M. Huang, et al. 2005. Cyclooxygenase 2 inhibition promotes IFN-γ-dependent enhancement of antitumor responses. J. Immunol. 175: 813-819.
-
(2005)
J. Immunol.
, vol.175
, pp. 813-819
-
-
Sharma, S.1
Zhu, L.2
Yang, S.C.3
Zhang, L.4
Lin, J.5
Hillinger, S.6
Gardner, B.7
Reckamp, K.8
Strieter, R.M.9
Huang, M.10
-
21
-
-
0033979545
-
Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis
-
Stolina, M., S. Sharma, Y. Lin, M. Dohadwala, B. Gardner, J. Luo, L. Zhu, M. Kronenberg, P. W. Miller, J. Portanova, et al. 2000. Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis. J. Immunol. 164: 361-370.
-
(2000)
J. Immunol.
, vol.164
, pp. 361-370
-
-
Stolina, M.1
Sharma, S.2
Lin, Y.3
Dohadwala, M.4
Gardner, B.5
Luo, J.6
Zhu, L.7
Kronenberg, M.8
Miller, P.W.9
Portanova, J.10
-
22
-
-
33244463813
-
Complex networks orchestrate epithelial-mesenchymal transitions
-
Thiery, J. P., and J. P. Sleeman. 2006. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol. 7: 131-142.
-
(2006)
Nat. Rev. Mol. Cell Biol.
, vol.7
, pp. 131-142
-
-
Thiery, J.P.1
Sleeman, J.P.2
-
23
-
-
0037093230
-
High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer
-
Bremnes, R. M., R. Veve, E. Gabrielson, F. R. Hirsch, A. Baron, L. Bemis, R. M. Gemmill, H. A. Drabkin, and W. A. Franklin. 2002. High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. J. Clin. Oncol. 20: 2417-2428.
-
(2002)
J. Clin. Oncol.
, vol.20
, pp. 2417-2428
-
-
Bremnes, R.M.1
Veve, R.2
Gabrielson, E.3
Hirsch, F.R.4
Baron, A.5
Bemis, L.6
Gemmill, R.M.7
Drabkin, H.A.8
Franklin, W.A.9
-
24
-
-
0035105335
-
E-cadherin expression associated with differentiation and prognosis in patients with non-small cell lung cancer
-
Liu, D., C. Huang, K. Kameyama, E. Hayashi, A. Yamauchi, S. Kobayashi, and H. Yokomise. 2001. E-cadherin expression associated with differentiation and prognosis in patients with non-small cell lung cancer. Ann. Thorac. Surg. 71: 949-954.
-
(2001)
Ann. Thorac. Surg.
, vol.71
, pp. 949-954
-
-
Liu, D.1
Huang, C.2
Kameyama, K.3
Hayashi, E.4
Yamauchi, A.5
Kobayashi, S.6
Yokomise, H.7
-
25
-
-
0344393065
-
The dynamic and motile properties of intermediate filaments
-
Helfand, B. T., L. Chang, and R. D. Goldman. 2003. The dynamic and motile properties of intermediate filaments. Annu. Rev. Cell Dev. Biol. 19: 445-467.
-
(2003)
Annu. Rev. Cell Dev. Biol.
, vol.19
, pp. 445-467
-
-
Helfand, B.T.1
Chang, L.2
Goldman, R.D.3
-
26
-
-
0035215429
-
Expression of E-cadherin and lymph node metastasis in resected non-small-cell lung cancer
-
Hirata, T., T. Fukuse, H. Naiki, and H. Wada. 2001. Expression of E-cadherin and lymph node metastasis in resected non-small-cell lung cancer. Clin. Lung Cancer 3: 134-140.
-
(2001)
Clin. Lung Cancer
, vol.3
, pp. 134-140
-
-
Hirata, T.1
Fukuse, T.2
Naiki, H.3
Wada, H.4
-
27
-
-
1042267263
-
Cell adhesion and signalling by cadherins and Ig-CAMs in cancer
-
Cavallaro, U., and G. Christofori. 2004. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat. Rev. Cancer. 4: 118-132.
-
(2004)
Nat. Rev. Cancer.
, vol.4
, pp. 118-132
-
-
Cavallaro, U.1
Christofori, G.2
-
28
-
-
33744925683
-
Cyclooxygenase-2-dependent regulation of E-cadherin: Prostaglandin E2 induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer
-
Dohadwala, M., S. C. Yang, J. Luo, S. Sharma, R. K. Batra, M. Huang, Y. Lin, L. Goodglick, K. Krysan, M. C. Fishbein, et al. 2006. Cyclooxygenase-2- dependent regulation of E-cadherin: prostaglandin E2 induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. Cancer Res. 66: 5338-5345.
-
(2006)
Cancer Res.
, vol.66
, pp. 5338-5345
-
-
Dohadwala, M.1
Yang, S.C.2
Luo, J.3
Sharma, S.4
Batra, R.K.5
Huang, M.6
Lin, Y.7
Goodglick, L.8
Krysan, K.9
Fishbein, M.C.10
-
29
-
-
0031226737
-
Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line
-
Chu, Y. W., P. C. Yang, S. C. Yang, Y. C. Shyu, M. J. Hendrix, R. Wu, and C. W. Wu. 1997. Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am. J. Respir. Cell Mol. Biol. 17: 353-360.
-
(1997)
Am. J. Respir. Cell Mol. Biol.
, vol.17
, pp. 353-360
-
-
Chu, Y.W.1
Yang, P.C.2
Yang, S.C.3
Shyu, Y.C.4
Hendrix, M.J.5
Wu, R.6
Wu, C.W.7
-
30
-
-
0347320748
-
Notch1 can contribute to viral-induced transformation of primary human keratinocytes
-
Lathion, S., J. Schaper, P. Beard, and K. Raj. 2003. Notch1 can contribute to viral-induced transformation of primary human keratinocytes. Cancer Res. 63: 8687-8694.
-
(2003)
Cancer Res.
, vol.63
, pp. 8687-8694
-
-
Lathion, S.1
Schaper, J.2
Beard, P.3
Raj, K.4
-
31
-
-
43949093802
-
Combination of Fasl and GM-CSF confers synergistic antitumor immunity in an in vivo model of the murine Lewis lung carcinoma
-
Ho, M. Y., G. H. Sun, S. J. Leu, S. M. Ka, S. J. Tang, and K. H. Sun. 2008. Combination of Fasl and GM-CSF confers synergistic antitumor immunity in an in vivo model of the murine Lewis lung carcinoma. Int. J. Cancer. 123: 123-133.
-
(2008)
Int. J. Cancer.
, vol.123
, pp. 123-133
-
-
Ho, M.Y.1
Sun, G.H.2
Leu, S.J.3
Ka, S.M.4
Tang, S.J.5
Sun, K.H.6
-
32
-
-
34848857434
-
Transforming growth factor-β and the immune response: Implications for anticancer therapy
-
Wrzesinski, S. H., Y. Y. Wan, and R. A. Flavell. 2007. Transforming growth factor-β and the immune response: implications for anticancer therapy. Clin. Cancer Res. 13: 5262-5270.
-
(2007)
Clin. Cancer Res.
, vol.13
, pp. 5262-5270
-
-
Wrzesinski, S.H.1
Wan, Y.Y.2
Flavell, R.A.3
-
34
-
-
33745388145
-
Signalling networks regulating cyclooxygenase-2
-
Tsatsanis, C., A. Androulidaki, M. Venihaki, and A. N. Margioris. 2006. Signalling networks regulating cyclooxygenase-2. Int. J. Biochem. Cell Biol. 38: 1654-1661.
-
(2006)
Int. J. Biochem. Cell Biol.
, vol.38
, pp. 1654-1661
-
-
Tsatsanis, C.1
Androulidaki, A.2
Venihaki, M.3
Margioris, A.N.4
-
35
-
-
29244449354
-
Prostaglandins and cancer
-
Wang, D., and R. N. Dubois. 2006. Prostaglandins and cancer. Gut 55: 115-122.
-
(2006)
Gut
, vol.55
, pp. 115-122
-
-
Wang, D.1
Dubois, R.N.2
-
36
-
-
40449118293
-
Immune modulation as a therapeutic strategy for non-small-cell lung cancer
-
Holt, G. E., and M. L. Disis. 2008. Immune modulation as a therapeutic strategy for non-small-cell lung cancer. Clin. Lung Cancer 9(Suppl. 1): S13-S19.
-
(2008)
Clin. Lung Cancer
, vol.9
, Issue.SUPPL. 1
-
-
Holt, G.E.1
Disis, M.L.2
-
37
-
-
33751568890
-
IL-27 induces Th1 differentiation via p38 MAPK/T-bet- And intercellular adhesion molecule-1/LFA-1/ERK1/2-dependent pathways
-
Owaki, T., M. Asakawa, F. Fukai, J. Mizuguchi, and T. Yoshimoto. 2006. IL-27 induces Th1 differentiation via p38 MAPK/T-bet- and intercellular adhesion molecule-1/LFA-1/ERK1/2-dependent pathways. J. Immunol. 177: 7579-7587.
-
(2006)
J. Immunol.
, vol.177
, pp. 7579-7587
-
-
Owaki, T.1
Asakawa, M.2
Fukai, F.3
Mizuguchi, J.4
Yoshimoto, T.5
-
39
-
-
34547187632
-
Several transcription factors regulate COX-2 gene expression in pancreatic β-cells
-
Zhang, X., J. Zhang, X. Yang, and X. Han. 2007. Several transcription factors regulate COX-2 gene expression in pancreatic β-cells. Mol. Biol. Rep. 34: 199-206.
-
(2007)
Mol. Biol. Rep.
, vol.34
, pp. 199-206
-
-
Zhang, X.1
Zhang, J.2
Yang, X.3
Han, X.4
-
40
-
-
2442674389
-
The role of Fas ligand and transforming growth factor β in tumor progression: Molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy
-
Kim, R., M. Emi, K. Tanabe, Y. Uchida, and T. Toge. 2004. The role of Fas ligand and transforming growth factor β in tumor progression: molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy. Cancer 100: 2281-2291.
-
(2004)
Cancer
, vol.100
, pp. 2281-2291
-
-
Kim, R.1
Emi, M.2
Tanabe, K.3
Uchida, Y.4
Toge, T.5
-
41
-
-
33845524970
-
Transforming growth factor-β in cancer and metastasis
-
Jakowlew, S. B. 2006. Transforming growth factor-β in cancer and metastasis. Cancer Metastasis Rev. 25: 435-457.
-
(2006)
Cancer Metastasis Rev.
, vol.25
, pp. 435-457
-
-
Jakowlew, S.B.1
-
42
-
-
34447345406
-
The biology and therapeutic potential of interleukin 27
-
Batten, M., and N. Ghilardi. 2007. The biology and therapeutic potential of interleukin 27. J. Mol. Med. 85: 661-672.
-
(2007)
J. Mol. Med.
, vol.85
, pp. 661-672
-
-
Batten, M.1
Ghilardi, N.2
-
44
-
-
0033052143
-
The toxicology of interleukin-12: A review
-
Car, B. D., V. M. Eng, J. M. Lipman, and T. D. Anderson. 1999. The toxicology of interleukin-12: a review. Toxicol. Pathol. 27: 58-63.
-
(1999)
Toxicol. Pathol.
, vol.27
, pp. 58-63
-
-
Car, B.D.1
Eng, V.M.2
Lipman, J.M.3
Anderson, T.D.4
-
45
-
-
33745685864
-
Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma
-
Oniki, S., H. Nagai, T. Horikawa, J. Furukawa, M. L. Belladonna, T. Yoshimoto, I. Hara, and C. Nishigori. 2006. Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma. Cancer Res. 66: 6395-6404.
-
(2006)
Cancer Res.
, vol.66
, pp. 6395-6404
-
-
Oniki, S.1
Nagai, H.2
Horikawa, T.3
Furukawa, J.4
Belladonna, M.L.5
Yoshimoto, T.6
Hara, I.7
Nishigori, C.8
|